Costs & hospitals · patient guide

Rare-Disease MDT Review in China: Charges Outside the Initial Estimate

An initial rare-disease MDT estimate normally covers the review itself, not every related step. Items such as additional specialist opinions, repeat pathology or genomic work, interpretation, records translation, extra appointments and travel are separate questions. Ask the provider to list what is included, what is excluded and what is undecided, then confirm who authorises each addition in writing before it proceeds.

Go to the practical guidance ↓
AI illustration: A doctor discusses medical documents with a patient in a consultation room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Why an MDT estimate is a starting scope, not a final bill

A multidisciplinary review brings two or three relevant specialties together for a complex or cross-specialty case. The estimate you receive describes that review. It does not automatically describe every document, test, opinion or visit that may become relevant once specialists start reading the file.

This is not a hidden-fee warning. It is a scope question. A rare-disease file often raises follow-up questions that were not visible when the estimate was written: a pathology slide that needs a second read, a genomic report that needs interpretation, a specialty that was not in the original panel. Each of those is a separate decision with its own authorisation.

The practical consequence is simple. If you treat the first estimate as the whole cost, you may approve work you did not intend to approve, or delay work that the review actually needs. If you treat it as a defined scope, you can decide item by item.

Items to confirm as inside or outside the review estimate

The following are categories to confirm with the named provider, not a universal list. Any of them may be inside the estimate, outside it, or not yet decided. The point is to ask, not to assume.

Additional specialist opinions. If the review panel covers two or three specialties and the case later needs a fourth, that is a new scope question. Ask whether the estimate names the specialties included and whether adding one changes the fee.

Repeat or extended laboratory work. A review is records-based. If the specialists ask for a new test, a repeat sample or an extended genomic panel, that is separate from reading existing records. Ask who orders it, where it is performed and how it is billed.

Pathology or imaging re-review. A second read of slides, blocks or scans is a distinct professional task. Ask whether it is inside the MDT fee, quoted separately, or not offered by that provider.

Interpretation and translation. If your records are not in Chinese, translation or certified interpretation may be needed before specialists can review them. Ask whether this is included, quoted separately, or handled by you.

Additional appointments. A review may lead to a follow-up consultation, a further panel meeting or an in-person visit. Ask whether the estimate covers one review or a series.

Administrative and travel items. Appointment coordination, hospital companion support, airport pickup, hotels and local transport are separate from the clinical review. Ask which of these, if any, the provider is quoting.

How to read the written estimate line by line

Ask for the estimate in writing and read it as a scope document, not a total. Three labels matter more than the number at the bottom: included, excluded and undecided.

Included means the provider has committed to that item within the quoted fee. Excluded means it is not part of this fee and will be handled separately. Undecided means the provider cannot yet say, usually because the clinical question is not settled. Undecided items are the ones most likely to surprise you later, so they deserve the most attention.

For each line, identify the payee. Some items are paid to the provider for coordination. Others are paid to a hospital, laboratory or another professional. Ask which is which, because it affects who you contact if something changes.

Also ask what triggers a revised estimate. A new specialty, a new test request or a change in the review question can all change scope. Knowing the trigger in advance lets you approve or decline before work begins.

  • Does the estimate name the specialties included in the review?
  • Does it state whether pathology, imaging or genomic re-review is inside or outside the fee?
  • Does it state who pays for translation or interpretation, and to whom?
  • Does it cover one review meeting or a series?
  • Does it list which items are still undecided?

Who authorises an addition, and how

Authorisation is a named person plus a written confirmation. Without both, an addition can proceed on an assumption that neither side intended.

Start by asking the provider to name the person who will contact you if the scope changes. That may be a coordinator, a case manager or a billing contact. Ask for the channel they will use: email, a written message or a document you sign.

Then agree the rule in advance. A workable rule is that no item outside the written estimate proceeds until you have received a short written description of the item, its purpose, its payee and its cost, and you have confirmed in writing that it may proceed.

Ask what happens if you decline. Sometimes the review can continue without the extra item. Sometimes it cannot, and the provider should tell you that clearly so you can decide whether to continue at all.

Keep one thread. If several people contact you, ask that all scope changes come through the named contact so you are not approving the same item twice or missing one.

Questions that prevent most billing surprises

These questions are worth sending before you pay anything. They are administrative, not clinical, and the provider should be able to answer them in writing.

What exactly does this fee cover, and what is the deliverable? A written review summary, a panel discussion, a records-based opinion or something else. The deliverable defines what you are buying.

Which items are excluded, and which are still undecided? Ask for both lists explicitly. An empty excluded list is a useful answer if it is accurate.

Who is the payee for each excluded item? Coordination fees and hospital or laboratory charges are separate, and they are paid to different parties.

What would change the estimate, and who would tell me? Ask for the trigger and the contact.

If I decline an addition, how does that affect the review? Ask whether the review can proceed, pause or stop.

Is a proxy consultation required before the MDT review? It is optional, not a prerequisite. Ask whether the provider recommends it for your case and why.

What to send, and the next step

You do not need to send a complete medical archive to start. An initial enquiry asks for a brief summary: the working diagnosis or main question, the key records you already have, and what you want the review to answer. The team checks what is available, identifies what is missing and suggests the relevant next step. This is not a diagnosis or a promise of acceptance.

After that first contact, you can share records through the channel the provider specifies. Ask which document formats they accept, whether translations are needed, and how the file will be handled. Those answers shape the scope of the estimate you will later receive.

The hospital and its clinicians decide suitability, the review question and any clinical recommendation. The provider's role is information and non-clinical coordination. Coordination fees and hospital or provider charges remain separate, and no service fee is credited, offset or refunded against later treatment, including surgery or any other care arranged in China. Ask the named provider to confirm in writing how its own coordination fee and any hospital or laboratory charges are billed, and to whom each is paid.

A practical next step: send a short summary through the enquiry form, email or WhatsApp, and ask for a written estimate that lists included, excluded and undecided items, names the contact who authorises changes, and states the payee for each item. An initial enquiry is free, and you can decide about any paid service after you have that written scope in hand.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. ChinaSpecialistCare: Rare-Disease MDT Review in China

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.